Health Canada is strengthening warnings on the labelling of metoclopramide

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1362卷 / 1期

关键词：

Public Health; Metoclopramide; Elderly Woman; Tardive Dyskinesia;

D O I：

10.2165/00128415-201113620-00010

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Tequin: labelling updates in US, warnings in Canada
[J]. Reactions Weekly, 2006, 1090 (1) : 3 - 3
[2] Health Canada strengthens warnings for promethazine
[J]. Reactions Weekly, 2010, 1299 (1) : 2 - 2
[3] Warnings on Metoclopramide Treatment Reply
Camilleri, Michael
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (10) : 1138 - 1139
[4] Droperidol: cardiovascular warnings issued by Health Canada
[J]. Reactions Weekly, 2002, 890 (1) : 3 - 3
[5] Simvastatin safety: impact of Health Canada warnings
[J]. Reactions Weekly, 2017, 1674 (1) : 11 - 11
[6] Canada to put health warnings on individual cigarettes
Kirby, Tony
[J]. LANCET ONCOLOGY, 2023, 24 (07): : 726 - 726
[7] Health warnings to be put on individual cigarettes in Canada
Kirby, Tony
[J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (08): : 671 - 671
[8] Canada: industry excuses over health warnings
Simpson, D
[J]. TOBACCO CONTROL, 2000, 9 (03) : 272 - 272
[9] Health Canada strengthens warnings for prescription opioids
[J]. Reactions Weekly, 2018, 1683 (1) : 6 - 6
[10] Health Canada to update TNF inhibitor labelling
[J]. Reactions Weekly, 2009, 1267 (1) : 2 - 2

← 1 2 3 4 5 →